Not recruitingISRCTN42305247
Antidepressant Controlled Trial for Negative Symptoms in schizophrenia
Research studyAges 18–65United Kingdom
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJuly 2011
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Imperial College London (UK)
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- United Kingdom
- Age range
- From 18 Years to 65 Years
- Official registry ID
- ISRCTN42305247
- Official title
Show the full official title
Individually Randomised, Placebo-controlled, Parallel Arm RCT With 12-month Follow-up to Establish the Clinical and Cost Effectiveness of the Antidepressant Citalopram in the Management of Negative Symptoms of Schizophrenia
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bristol · Derby · Lincoln
7 more locations
- London
- Manchester
- Newcastle
- Oxford
- Sheffield
- Southampton
- Stafford
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Imperial College London (UK), a university.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to explore more studies?
Explore studiesRelated studies
A brief imagery intervention for future-oriented mental images
A double-blind randomised controlled trial of repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of persistent auditory hallucinations in schizophrenia